Molecular and Cellular Pharmacology
ISSN 1938-1247
Molecular and Cellular Pharmacology is important reading for scientists and clinicians engaged in basic, clinical and translational research. The journal publishes Research Articles, Reviews and PharmSights in all areas broadly related to Pharmacological Sciences.
Molecular and Cellular Pharmacology is indexed by Academic Journals Database; CAB Abstracts; CAS Source Index (CASSI); Crossref; Directory of Open Access Scholarly Resources (ROAD); Free Medical Journals; GenamicsJournalSeek; Global Health; Google Scholar; JournalGuide (in the whitelist of reputable titles); OALib; Research4Life; Semantic Scholar; Scopus; WorldCat Discovery.
Journal Impact 2018
Impact (Scopus CiteScore): 1.10
H Index: 21
SJR: 0.366
SNIP: 0.876
CiteScore percentile: 48%
CiteScore rank: 84 out of 163 pharm journals
NIH-funded articles are deposited in PubMed Central. Find Mol. Cell. Pharmacol. articles in PubMed
Conferences & Funding Opportunities
Vol 15, No 1 (2023)
Table of Contents
-
Sacituzumab Govitecan for Hormone Receptor-positive and Triple-negative Breast Cancers
Review
Mol Cell Pharmacol 2023; 15(1):1-5. -
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
FDA News Release
Mol Cell Pharmacol 2023; 15(1):7. -
FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis
FDA News Release
Mol Cell Pharmacol 2023; 15(1):7-8. -
FDA Approves First Over-the-Counter Naloxone Nasal Spray
Agency Continues to Take Critical Steps to Reduce Drug Overdose Deaths Being Driven Primarily by Illicit Opioids
FDA News Release
Mol Cell Pharmacol 2023; 15(1):8-9.
Vol 15, No 2 (2023)
Table of Contents
-
FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria
FDA News Release
Mol Cell Pharmacol 2023; 15(2):00. -
FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes
FDA News Release
Mol Cell Pharmacol 2023; 15(2):00. -
FDA Approves New Drug to Prevent RSV in Babies and Toddlers
FDA News Release
Mol Cell Pharmacol 2023; 15(2):00.
Vol 15, No 3 (2023)
Table of Contents
-
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes
FDA News Release
Mol Cell Pharmacol 2023; 15(3):00. -
FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder
FDA News Release
Mol Cell Pharmacol 2023; 15(3):00. -
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
FDA News Release
Mol Cell Pharmacol 2023; 15(3):00.